期刊
INFORMATION FUSION
卷 66, 期 -, 页码 170-183出版社
ELSEVIER
DOI: 10.1016/j.inffus.2020.09.002
关键词
Alzheimer's disease; Multimodal neuroimaging; Multiple kernel learning; Feature selection; Neuroimaging biomarker; Multiclass classification; Multimodal fusion
资金
- Alzheimer's Disease Neuroimaging Initiative (ADNI), USA (National Institutes of Health) [U01 AG024904]
- DOD ADNI, USA (Department of Defense) [W81XWH-12-2-0012]
- National Institute on Aging
- National Institute of Biomedical Imaging and Bioengineering
- AbbVie
- Alzheimer's Association
- Alzheimer's Drug Discovery Foundation
- Araclon Biotech
- BioClinica, Inc.
- Biogen
- Bristol-Myers Squibb Company
- CereSpir, Inc.
- Cogstate
- Eisai Inc.
- Elan Pharmaceuticals, Inc.
- Eli Lilly and Company
- EuroImmun
- F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.
- Fujirebio
- GE Healthcare
- IXICO Ltd.
- Janssen Alzheimer Immunotherapy Research & Development, LLC.
- Johnson & Johnson Pharmaceutical Research & Development LLC.
- Lumosity
- Lundbeck
- Merck Co., Inc.
- Meso Scale Diagnostics, LLC.
- NeuroRx Research
- Neurotrack Technologies
- Novartis Pharmaceuticals Corporation
- Pfizer Inc.
- Piramal Imaging
- Servier
- Takeda Pharmaceutical Company
- Transition Therapeutics
- Canadian Institutes of Health Research
The study introduces a novel multiclass classification framework for AD based on multimodal neuroimaging with embedded feature selection and fusion. By using regularization and optimization techniques, it achieves feature selection and fusion, proving the convergence of the optimization process. Experimental results demonstrate the method's promising performance.
Alzheimer's disease (AD) will become a global burden in the coming decades according to the latest statistical survey. How to effectively detect AD or MCI (mild cognitive impairment) using reliable biomarkers and robust machine learning methods has become a challenging problem. In this study, we propose a novel AD multiclass classification framework with embedding feature selection and fusion based on multimodal neuroimaging. The framework has three novel aspects: (1) An l(2,1)-norm regularization term combined with the multiclass hinge loss is used to naturally select features across all the classes in each modality. (2) To fuse the complementary information contained in each modality, an l(p)-norm (1 < p < infinity) regularization term is introduced to combine different kernels to perform multiple kernel learning to avoid a sparse kernel coefficient distribution, thereby effectively exploiting complementary modalities. (3) A theorem that transforms the multiclass hinge loss minimization problem using the l(2,1)-norm and l(p)-norm regularizations to a previous solvable optimization problem and its proof are given. Additionally, it is theoretically proved that the optimization process converges to the global optimum. Extensive comparison experiments and analysis support the promising performance of the proposed method.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据